Neil Floch MD FACS FASMBS DABOM
@neilflochmd.bsky.social
Bariatric and Foregut Surgeon passionate about educating and advocating about obesity causes and treatments including medications and bariatric surgery - Associate Professor of Surgery Yale School of Medicine and a self-taught artist - Tufts Graduate
Intussusception is a condition or complication where one part of the intestine telescopes into another. It can occur from a mass of the bowel such as a polyp or growth or from fixed point such as in bowel or gastric bypass surgery. #obesity #pediatric surgery #gastricbypass
November 3, 2025 at 5:47 PM
Intussusception is a condition or complication where one part of the intestine telescopes into another. It can occur from a mass of the bowel such as a polyp or growth or from fixed point such as in bowel or gastric bypass surgery. #obesity #pediatric surgery #gastricbypass
The Yale Obesity Symposium
A one-day 7 CME event
November 21 2025
NEW developments in
Obesity Treatment
Speakers including:
Lee Kaplan MD PhD
Ania Jastreboff MD PhD
John Morton MD
Register NOW! cme.edu
@Yale @YaleMed @YaleSurgery
Obesity GLP-1ra Semaglutide Tirzepatide Retatrutide GLP1
A one-day 7 CME event
November 21 2025
NEW developments in
Obesity Treatment
Speakers including:
Lee Kaplan MD PhD
Ania Jastreboff MD PhD
John Morton MD
Register NOW! cme.edu
@Yale @YaleMed @YaleSurgery
Obesity GLP-1ra Semaglutide Tirzepatide Retatrutide GLP1
October 18, 2025 at 1:25 PM
The Yale Obesity Symposium
A one-day 7 CME event
November 21 2025
NEW developments in
Obesity Treatment
Speakers including:
Lee Kaplan MD PhD
Ania Jastreboff MD PhD
John Morton MD
Register NOW! cme.edu
@Yale @YaleMed @YaleSurgery
Obesity GLP-1ra Semaglutide Tirzepatide Retatrutide GLP1
A one-day 7 CME event
November 21 2025
NEW developments in
Obesity Treatment
Speakers including:
Lee Kaplan MD PhD
Ania Jastreboff MD PhD
John Morton MD
Register NOW! cme.edu
@Yale @YaleMed @YaleSurgery
Obesity GLP-1ra Semaglutide Tirzepatide Retatrutide GLP1
A message from @OMAsocial past PRESIDENT and #OAC board member @DrAngelaFitch:
IT IS TIME for #GLP1 #obesity medication pharmaceutical producers to:
#betheHERO #betheHERO!
Cut the cost to $299 a month and Increase access to care!
IT IS TIME for #GLP1 #obesity medication pharmaceutical producers to:
#betheHERO #betheHERO!
Cut the cost to $299 a month and Increase access to care!
April 12, 2025 at 12:20 AM
A message from @OMAsocial past PRESIDENT and #OAC board member @DrAngelaFitch:
IT IS TIME for #GLP1 #obesity medication pharmaceutical producers to:
#betheHERO #betheHERO!
Cut the cost to $299 a month and Increase access to care!
IT IS TIME for #GLP1 #obesity medication pharmaceutical producers to:
#betheHERO #betheHERO!
Cut the cost to $299 a month and Increase access to care!